Welcome to our dedicated page for Psybio Therapeau news (Ticker: PSYBF), a resource for investors and traders seeking the latest updates and insights on Psybio Therapeau stock.
PsyBio Therapeutics Corp (PSYBF) is an intellectual property-driven biotechnology company focused on developing novel, bespoke, psycho-targeted therapeutics to enhance mental and neurological health. With recent government approval to manufacture biosynthetic tryptamines, including their lead compound PsyBio-11142, the company is poised to advance to human clinical trials. PsyBio's bio-medicinal chemistry approach involves utilizing psychoactive compounds as templates for developing precursors and analogs, with ongoing research in naturally occurring tryptamines found in hallucinogenic mushrooms and other sources. The company's leadership role in the industry is underscored by its commitment to scientific advancements and therapeutic development.
PsyBio Therapeutics Corp. (TSXV: PSYB, OTCQB: PSYBF) will be presenting at the KCSA Psychedelics Investor Conference on October 14th at 10:30 a.m. ET. The conference aims to showcase innovative biotechnology focused on developing psycho-targeted therapeutics for mental health improvement. Interested participants can register here. PsyBio's expertise lies in drug discovery through synthetic biology and metabolic engineering, utilizing psychoactive compounds derived from hallucinogenic mushrooms to develop novel therapies.
PsyBio Therapeutics Corp. (OTCQB: PSYBF) announced the commencement of trading of its subordinate voting shares on the OTCQB Venture Market on July 14, 2021. This listing aims to increase visibility among U.S. investors and enhance liquidity for shareholders. The company is also applying for DTC eligibility, which will facilitate electronic settlement of stock transfers, making it easier for investors. PsyBio continues to trade on the TSX Venture Exchange as PSYB and on the Frankfurt Stock Exchange as PSYB.F.
FAQ
What is the current stock price of Psybio Therapeau (PSYBF)?
What is the market cap of Psybio Therapeau (PSYBF)?
What is PsyBio Therapeutics Corp focused on?
What recent achievement has PsyBio made?
What is PsyBio's approach to therapeutic development?
What is PsyBio's research focus?
How does PsyBio demonstrate leadership in the industry?
